These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8043984)

  • 21. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
    Khare SD; Luthra HS; David CS
    Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis.
    D'Amato M; Fiorillo MT; Carcassi C; Mathieu A; Zuccarelli A; Bitti PP; Tosi R; Sorrentino R
    Eur J Immunol; 1995 Nov; 25(11):3199-201. PubMed ID: 7489765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arthritis in HLA-B27 transgenic animals.
    Taurog JD
    Am J Med Sci; 1998 Oct; 316(4):250-6. PubMed ID: 9766486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathogenetic role of HLA-B27 in chronic arthritis.
    López de Castro JA
    Curr Opin Immunol; 1998 Feb; 10(1):59-66. PubMed ID: 9523113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the pathogenesis of ankylosing spondylitis.
    Dakwar E; Reddy J; Vale FL; Uribe JS
    Neurosurg Focus; 2008; 24(1):E2. PubMed ID: 18290740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity.
    Sorrentino R; Böckmann RA; Fiorillo MT
    Mol Immunol; 2014 Jan; 57(1):22-7. PubMed ID: 23916069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.
    Khare SD; Bull MJ; Hanson J; Luthra HS; David CS
    J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel human aggrecan T cell epitopes in HLA-B27 transgenic mice associated with spondyloarthropathy.
    Kuon W; Kuhne M; Busch DH; Atagunduz P; Seipel M; Wu P; Morawietz L; Fernahl G; Appel H; Weiss EH; Krenn V; Sieper J
    J Immunol; 2004 Oct; 173(8):4859-66. PubMed ID: 15470026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria.
    García F; Marina A; Albar JP; López de Castro JA
    Tissue Antigens; 1997 Jan; 49(1):23-8. PubMed ID: 9027961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenetic basis of the seronegative spondyloarthropathies.
    Ivanyi P
    Curr Opin Rheumatol; 1992 Aug; 4(4):484-93. PubMed ID: 1503871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin.
    Wildner G; Diedrichs-Möhring M; Thurau SR
    Eur J Immunol; 2002 Jan; 32(1):299-306. PubMed ID: 11782021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-B27.
    Bowness P
    Annu Rev Immunol; 2015; 33():29-48. PubMed ID: 25861975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.
    Appel H; Kuon W; Kuhne M; Wu P; Kuhlmann S; Kollnberger S; Thiel A; Bowness P; Sieper J
    Arthritis Res Ther; 2004; 6(6):R521-34. PubMed ID: 15535830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mimicry between human leukocyte antigen B27 and Klebsiella. Consequences for spondyloarthropathies.
    Schwimmbeck PL; Oldstone MB
    Am J Med; 1988 Dec; 85(6A):51-3. PubMed ID: 2462350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenetics of the spondyloarthropathies.
    Ivanyi P
    Curr Opin Rheumatol; 1993 Jul; 5(4):436-45. PubMed ID: 8357740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guilt by association: HLA-B27 and ankylosing spondylitis.
    Benjamin R; Parham P
    Immunol Today; 1990 Apr; 11(4):137-42. PubMed ID: 2187471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution.
    Scofield RH; Warren WL; Koelsch G; Harley JB
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9330-4. PubMed ID: 8415702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.
    Khare SD; Luthra HS; David CS
    J Exp Med; 1995 Oct; 182(4):1153-8. PubMed ID: 7561688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies.
    Boyle LH; Hill Gaston JS
    Rheumatology (Oxford); 2003 Mar; 42(3):404-12. PubMed ID: 12626789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.